
Prediction: 12 months from now, AstraZeneca’s share price could be…
After rising by over 20% since November, the AstraZeneca (LSE:AZN) share price is on a good run. And now management has just signed a $1bn deal to acquire EsoBiotec and further secure its long-term cancer therapy product portfolio. So, with the pharma …